Close menu




October 13th, 2026 | 05:26 CEST

Almonty Industries, Rheinmetall, Lockheed Martin – Tungsten, Defence and a Share Price Decline That Could Open Up Opportunities

  • Almonty Industries
  • Rheinmetall
  • Lockheed Martin
  • Tungsten
  • Tungsten Mine
  • Tungsten Concentrate
  • Sangdong
  • Defence
  • Defence Industry
Photo credits: Pixabay / WikiImages

Sangdong is producing tungsten again for the first time since 1993. Almonty's South Korean mine is now supplying a raw material from outside China that is urgently needed in defence and is also found in an increasing number of high-tech devices. China's export restrictions have driven up tungsten prices in the West, while demand remains strong. The same is true of defence. On September 14, Rheinmetall booked an order for tens of thousands of artillery shells, while Lockheed Martin announced a framework agreement worth up to USD 1.2 billion for tactical missiles on September 21. Yet the stock market has so far shown little reaction to these developments. All three stocks are under pressure. We therefore take a closer look at Almonty Industries, Rheinmetall and Lockheed Martin.

time to read: 5 minutes | Author: Armin Schulz
ISIN: Almonty Industries Inc | CA0203987072 , RHEINMETALL AG | DE0007030009 , LOCKHEED MARTIN | US5398301094

Almonty Industries: Tungsten Production at Sangdong Gets Underway

On September 21, the Sangdong processing plant received its final operating certificates, which had been issued on September 17. This officially cleared Phase I for commercial operations. Two days later, Almonty Industries announced the site's first tungsten production since 1993, a 33-year milestone. In a shareholder letter dated September 29, the company reported that Phase II was progressing. The expansion is expected to be completed as early as 2027 and is set to raise capacity to up to 1.2 million tonnes of ore per year, with annual output of around 460,000 MTU. The mill initially operated 13 hours a day, but according to CEO Lewis Black at the International Investment Forum, that has since increased to 16 hours.

In parallel, Almonty is expanding its raw material sources. On September 14, the company signed a binding agreement with the government of Rwanda, which will receive a 25% stake in Almonty Rwanda, while Almonty retains 75%. The government is contributing the 32 km² Shyorongi exploration concession and a processing licence. On September 17, this was followed by a supply agreement with Wolfram Bergbau und Hütten AG, a subsidiary of the Sandvik Group, for concentrate from the tailings of the Spanish Los Santos mine, with an offtake commitment for at least approximately 1,720 tonnes of contained tungsten trioxide. From January 1 2027, US restrictions on tungsten from China, Russia, North Korea and Iran will also apply.

On the stock market, the shares remain under pressure despite the positive news. On October 9, they closed at USD 11.87 on NASDAQ, down 32.71% from USD 17.64 on September 1. By the end of September, Almonty had repurchased 2,914,739 shares for around USD 48 million. Jefferies initiated coverage on September 2 with a Buy rating and a price target of USD 26.25, followed by Stifel on September 24 with USD 25.00. On September 18, DA Davidson reaffirmed its Buy recommendation with a target of USD 33.00. Goldman Sachs is more critical, setting its price target at USD 13.00, as it expects tungsten prices to fall and a slower ramp-up in Sangdong. If the ramp-up succeeds, it could boost the shares. According to the CEO, the vessel for the first shipment of the tungsten concentrate produced is booked for October 24.

Rheinmetall: Ammunition, Satellites and More Room to Grow

Rheinmetall's products remain in demand. On September 14, the Düsseldorf-based group announced an order for several tens of thousands of 155 mm artillery shells for an international customer. The value is in the low hundreds of millions of euros, production is under way, and completion is planned for 2027. According to the announcement, the order was booked in the third quarter of 2026. On September 30, this was followed by an order from the US Army for MK93 mounts worth USD 20.7 million, comprising 3,104 new mounts and upgrades to 245 existing ones. Delivery is scheduled for completion by October 2027.

The business is also gaining momentum beyond ammunition. On October 6, the group announced that the Bundeswehr will receive exclusive access to radar satellites through its subsidiary Rheinmetall ICEYE Space Solutions. Production in Neuss has started, with plans for several dozen satellites per year. The first satellite had already been launched into orbit jointly with Argotec on October 2. On October 8, Rheinmetall doubled its syndicated credit facility ahead of schedule from EUR 750 million to EUR 1.5 billion. According to media reports, the group also reaffirmed its targets for 2026 on October 5.

That is not enough for the stock market. On October 9, shares ended Xetra trading at EUR 939.10, down from EUR 1,079.80 on September 1, a 13.03% decline. Analysts' price targets nevertheless remain above that level. Deutsche Bank reaffirmed a price target of EUR 1,800.00 on October 6, while RBC cited EUR 1,600.00 on October 9 and also recommended buying. Bernstein lowered its target to EUR 1,200.00 on the same day, while Berenberg downgraded the shares to Hold due to uncertain prospects beyond 2030, with a target of EUR 1,020.00. If the deadlock over the Arminius tank procurement programme is broken by the end of 2026, as media reports suggest, the pullback could prove to be a buying opportunity. If the contract fails to materialise, that tailwind will be absent.

Lockheed Martin: Missiles in Demand, Dividend Increased

Demand for missiles is high, and Lockheed Martin is delivering. On September 21, the US defence group announced an Army framework contract worth up to USD 1.2 billion for the PrSM Increment 2 precision missile. A second flight test in August had demonstrated that it can hit moving maritime targets. Lockheed intends to quadruple production. On October 9, the group unveiled PAC-3 Edge, a new interceptor missile for an Army programme. Testing begins in 2027, with operational readiness planned by 2031. Lockheed invested USD 250 million in the Strigo Product Center.

Shareholders also benefit. On October 9, the board of directors increased the fourth-quarter dividend to USD 3.60 per share, up USD 0.15 from the previous quarter. The record date is December 1, with payment on December 31. Meanwhile, the group is growing through acquisitions. On July 6, Lockheed agreed to acquire Ultra Maritime for USD 3.45 billion. The underwater warfare specialist is set to join the Rotary and Mission Systems division following completion. According to the second-quarter figures, the order backlog stood at USD 230.4 billion as at June 28.

Yet the shares are declining. On October 9, they closed at USD 509.59, compared with USD 544.50 on September 1, a decline of 6.41%. They are 16.28% below the high of USD 608.68 reached on August 14. Rothschild & Co Redburn sets the price target at USD 650.00 and recommends buying, while Barclays is more cautious and sets the target at USD 554.00. TD Cowen lowered its price target on October 9 from USD 600 to USD 570 and maintained its Hold rating. On October 22, the group will present its third-quarter results. If Lockheed confirms its guidance, this could give the shares a boost.

Conclusion

Tungsten and defence are in high demand, yet the stocks are under pressure. Almonty Industries is ramping up its Sangdong mine, Phase II is progressing, and additional sources in Rwanda and Spain are expanding its supply base. If the Sangdong ramp-up succeeds, the recent pullback may have been excessive. Rheinmetall supplies ammunition and satellites and has greater financial flexibility, even as Bernstein and Berenberg have lowered their price targets. Lockheed Martin is increasing its dividend and focusing on missile systems, with its next earnings report due on October 22. Demand is there, but the stock market is still hesitant.


Conflict of interest

Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
In this respect, there is a concrete conflict of interest in the reporting on the companies.

In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is also a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

Risk notice

Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


Der Autor

Armin Schulz

Armin Schulz

Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

About the author



Related comments:

Commented by Fabian Lorenz on October 13th, 2026 | 05:36 CEST

Plug Power Losing Hope? Renk Stuck in a Downtrend? RE Royalties Riding the AI Boom!

  • Energy
  • solar energy
  • Wind energy
  • Hydrogen
  • Defence

A look at Renk's share chart brings no joy. Whether over four weeks, six months or 12 months, the share's performance is deep in the red. Analysts recommend buying, but momentum is lacking across the entire defence sector. The latest order does nothing to change that, even if it shows future potential. For AI to realise its full potential, it needs vast amounts of energy. Accordingly, hundreds of billions of US dollars are being invested in energy infrastructure, particularly in North America. This is precisely the market in which RE Royalties operates with an interesting business model. In its latest interview, the company looks to the future with optimism. By contrast, even Plug Power's most optimistic supporters are probably despairing by now.

Read

Commented by Lars Winter on October 12th, 2026 | 05:45 CEST

Almonty, 2G Energy and Redcare Pharmacy: Three Exciting Stocks with Fresh Momentum

  • Almonty
  • Tungsten
  • Commodities
  • 2G Energy
  • Energy
  • Heat Pumps
  • Redcare Pharmacy
  • Medicines
  • Health
  • Medicine

New orders, higher forecasts, and the transition from project developer to producer: The news outlook for Almonty Industries, 2G Energy, and Redcare Pharmacy has improved significantly recently. The three companies serve completely different markets. What they have in common is that they must now translate high expectations into measurable growth. We take a closer look at these three stocks.

Read

Commented by Stefan Bode on October 9th, 2026 | 07:25 CEST

Between New Beginnings and a Test of Resilience: Almonty Industries, Aumovio and SUSS MicroTec

  • Tungsten
  • Defense
  • CriticalMetals
  • semiconductor
  • Automotive

A surprising leadership change, strategically critical raw materials, and record orders amid falling share prices: Three publicly traded companies show how closely opportunities and risks are currently intertwined. While an automotive supplier struggles to improve margins, a tungsten producer is expanding its Western supply chains, and a semiconductor equipment manufacturer is tapping into new markets. Which developments justify optimism—and where must investors remain patient? This report examines what could be decisive for the next price movement.

Read